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Abstract 
The antimicrobial activity of polymyxins against Gram-negative bacteria has been known for 
several decades, but the mechanism of action leading to cell death has not been fully explored. 
A key step after binding of the antibiotic to lipopolysaccharide (LPS) exposed at the cell 
surface is "self-promoted uptake" across the outer membrane (OM), in which the antibiotic 
traverses the asymmetric LPS-phospholipid bilayer before reaching the periplasm and finally 
targeting and disrupting the bacterial phospholipid inner membrane. The work described here 
was prompted by the hypothesis that polymyxins might interact with proteins in the OM, as 
part of their self-promoted uptake and permeabilizing effects. One way to test this is through 
photolabeling experiments. We describe the design and synthesis of a photoprobe based upon 
polymyxin B, containing photoleucine and an N-acyl group with a terminal alkyne suitable 
for coupling to a biotin tag using click chemistry. The resulting photoprobe retains potent 
antimicrobial activity, and in initial photolabeling experiments with Escherichia coli 
ATCC25922 is shown to photolabel several OM proteins. This photoprobe might be a 
valuable tool in more detailed studies on the mechanism of action of this family of antibiotics. 
 
Key words: peptide, antibiotic, membrane protein, polymyxin, mechanism of action, click 
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Graphical Table of Contents 
A combined solid-phase peptide synthesis and solution macrocyclization approach to a 
photolabeling probe based upon polymyxin B is described. The probe contains a diazirine 
(photoleucine) and an alkyne for conjugation using click chemistry. The probe photolabels 
outer membrane proteins in Escherichia coli. 
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Introduction 
The polymyxins comprise a small family of macrocyclic cationic/hydrophobic decapeptide 
antibiotics with an N-terminal fatty acid chain [1] (Figure 1), which are produced naturally by 
Bacillus sp. [2,3]. They are used clinically for the treatment of serious infections caused by 
multi-drug resistant Gram-negative bacteria, such as Escherichia coli, Pseudomonas 
aeruginosa, Acinetobacter baumanii and Klebsiella sp., despite earlier concerns about 
nephrotoxicity and neurotoxicity [4,5]. The mechanism of action of polymyxins has been 
extensively studied, but still remains incompletely understood. The selective antimicrobial 
activity against Gram-negative bacteria arises due to an initial interaction of the cationic 
polymyxins with the negatively charged lipid A portion of lipopolysaccharide (LPS) in the 
outer leaflet of the asymmetric outer membrane (OM). NMR studies have provided models 
for the polymyxin-LPS complex [6], with the binding site lying within the negatively charged 
lipid A head-group of LPS (reviewed in [3]). Passage across the OM is proposed to occur by 
self-promoted uptake, in which the polymyxins exploit their own potent permeabilizing effect 
on the LPS-phospholipid bilayer to traverse the OM [7-9]. After gaining access to the 
periplasm, the antibiotic can bind and disrupt the inner cytoplasmic membrane (CM) in a 
process, which may include membrane depolarization, mixing of lipid components between 
bilayers, and leakage of contents from the cytoplasm, and culminates in cell death [10-13]. 
 Nevertheless, the relationships between bacterial killing and the interactions of 
polymyxins with the OM and CM are complex and incompletely understood [14]. Some 
evidence suggests that the concentrations of polymyxin that result in rapid bacterial killing are 
insufficient to cause depolarization of the CM [15]. Also, pore formation and depolarization 
of the CM seem not to be obligatory for the bactericidal action of polymyxin [13]. Moreover, 
the OM permeabilizing effect of the de-N-acylated form of polymyxin B (called polymyxin 
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nonapeptide) was shown to be strongly enantioselective, whereas binding to LPS was not [16]. 
This suggests that another key chiral bacterial receptor-polymyxin interaction in bacteria 
likely exists. One possibility is that polymyxins might interact with OM proteins in Gram-
negative bacteria as part of the mechanism of self-promoted uptake, although this has not 
been reported to date. In this work, we set out to design and synthesize a photoaffinity probe 
that might be used to detect interactions between polymyxins and OM proteins in 
photolabeling experiments. 
 We report here the design and synthesis of a photoprobe based upon polymyxin B3, 
and results of initial photolabeling experiments, which indeed reveal its interaction with 
several OM proteins in E. coli ATCC25922. 
 
Materials and Methods 
Synthesis. For the synthesis of photoprobe Pal-PMB solid-phase Fmoc chemistry [17] was 
used with an orthogonal Alloc protecting group on the Dab4 side chain. Fmoc-Thr(tBu)-OH 
(0.1 mmol) was first coupled to chlorotrityl chloride resin and the peptide chain was 
assembled using HBTU/HOBt and iPr2EtN in DMF for coupling reactions and piperidine in 
DMF (20%) for Fmoc-deprotection. L-PhotoLeu-OH was from Thermo Fisher Scientific 
(Rockford, Illinois). Unreacted amines were capped after each coupling step with acetic 
anhydride, iPr2EtN and HOBt in DMF. To remove the Alloc group, the resin was treated with 
Pd(PPh3)4 (1 eq.), Bu3SnH (12 eq.), and p-nitrophenol (2 eq.) in dry DCM under nitrogen in 
the dark for 1 h. The resin was then drained and the process repeated. The resin was washed 
with DCM (2x), with 0.5% sodium dithiodiethylcarbamate in DMF (2x), dry DMF (3x) and 
again with DCM (2x). The peptide was then cleaved from the resin with 0.8% TFA in DCM 
and the acid was immediately neutralized with iPr2EtN. The solvent was removed, DMF (0.5 
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ml) was added, and the peptide crude was precipitated with water and collected by 
centrifugation. The precipitate was taken up in a water-acetonitrile mixture and lyophilized. 
Cyclization was performed with diphenylphosphoryl azide (Dppa) (0.5 mmol, 5 eq.) and N-
methylmorpholine (NMM) (1 mmol, 10 eq.) in DMF and DMSO (2:1) under argon. The 
crude peptide was then taken up in 2% DBU and 2% piperidine in DMF (3 ml) and stirred for 
20 min at room temperature. Ice-cold water was added to precipitate crude product, which 
was collected by centrifugation and redissolved in MeCN/water and lyophilized. 7-Octynoic 
acid (3 eq.) was coupled in solution to the peptide using HBTU (2.9 eq.), HOBt (2.9 eq.) and 
iPr2EtN (11 eq.) in DMF. The solvent was then removed in vacuo. The crude peptide was then 
dissolved in TFA/TIS/H2O (95:2.5:2.5, 5 ml) at 0oC for 40 min. Addition of ice-cold 
diisopropyl ether precipitated the peptide, which was collected and washed twice with 
diisopropyl ether. The product was purified by reversed phase HPLC on a Waters XBridge™ 
(C8, 100 x 19 mm, 5 μm, OBD™) column with a gradient of 10-35% MeCN/H2O + 0.1% 
TFA in 4 column volumes. Yield 8.1 mg (7%), >95% purity. Retention time tR = 8.3 min 
(GRACE VYDAC® 214TP54, C4, 5 μm, 4.6 x 250 mm, flow 1 ml/min, gradient 10-50% 
MeCN/H2O + 0.1% TFA over 12.5 min); HR-ESI-MS: m/z (M+2H+) 599.3456 (calc. 
mass = 599.3467). The 1H NMR spectrum and assignments are in the Supporting Information. 
For the synthesis of polymyxin B3 a similar method was used, except that n-octanoic acid 
was coupled to the peptide-N-terminus on the resin, while macrocyclization was again 
performed in solution. The product was purified by preparative reverse phase HPLC on a 
Waters XBridge™ (C8, 100 x 19 mm, 5 μm, OBD™) column with a gradient of 10-35% 
MeCN/H2O + 0.1% TFA in 4 column volumes. The product was of >95% purity by reversed 
phase HPLC. Yield = 5.0 mg (4%). Retention time tR = 9.9 min (GRACE VYDAC® 214TP54, 
C4, 5 μm, 4.6 x 250 mm, flow 1 ml/min, gradient 10-50% MeCN/H2O + 0.1% TFA over 12.5 
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min); HR-ESI-MS: m/z (M+2H+) 595.3744 (calc. mass = 595.3744). The 1H NMR spectrum 
and assignments are in the Supporting Information. 
Determination of MIC. Antimicrobial activity was assayed against Escherichia coli 
ATCC25922 and P. aeruginosa PAO1 using the Clinical and Laboratory Standards Institute 
broth microdilution method in cation-adjusted Mueller-Hinton-II broth supplemented with 
0.02% BSA (Roche-Applied-Science, Fraction V, Rotkreuz) [18]. The MIC values are 
typically 4-8 fold lower when the assays are performed in Mueller-Hinton-I broth in the 
presence of 0.02% BSA. 
Photolabeling experiments.  E. coli ATCC25922 was grown in Mueller-Hinton II medium at 
37 °C to an OD600 of 1.0. Cells were resuspended in cold phosphate-buffered saline (PBS) 
(140 mM NaCl, 10 mM phosphate, pH 7.4). Aliquots of the cell suspension were transferred 
to borosilicate-flasks, diluted with PBS to a final OD of 1, and incubated with Pal-PMB (1 
µg/ml) for 15 min at 37 °C in the dark, and then irradiated under gentle stirring at 37 °C for 
15 min in a Rayonet-reactor (350 nm, 16 x 8 W Sylvania blacklight 350 F8W/T5/BL350 
lamps, in a 10 cm diameter array). After photolysis, the labelled cells were centrifuged (20 
min, 4000 rpm), washed once with ice-cold PBS, and the cell pellet could be stored at -20 °C. 
 Membrane protein isolation was performed by a modified carbonate extraction 
method [19]. Labelled cells resuspended in phosphate buffer (20 ml, 50 mM, pH 7.4) with 
benzamidine (1.25 µM), phenylmethanesulfonylfluoride (1 µM) and DTT (1 µM) were 
disrupted by sonication and unbroken cells removed by centrifugation at 4000 rpm for 20 min. 
The supernatant was diluted with ice-cold 0.1 M sodium carbonate (30 ml) and incubated 
with shaking at 100 rpm for 1 h at 4 °C. The membrane precipitate was collected by 
ultracentrifugation in a Sorvall T-865 rotor (ThermoFisher Scientific, Rockford, Illinois) at 
45000 rpm for 1 h at 4 °C. The supernatant was discarded and the pellet resuspended in 
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phosphate buffer (50 mM, pH 7.4) and centrifuged again at 45000 rpm for 1 h at 4 °C. This 
washing step was repeated. The pellet (ca. 30 µl paste) was resuspended in phosphate buffer 
(100 µl, 50 mM, pH 7.4). Aliquots (29 µl) were taken and phosphate buffer (5µl, 50 mM, pH 
7.4) with 14% SDS was added and the sample was heated to 100 oC for 3 min to denature OM 
proteins. Biotin-PEG2-N3 (2.2 µl of 0.15 mM in DMSO), aminoguanidine (5 µl of 5 mM in 
H2O) were added and the sample vortexed. CuSO4 (5 µl of 1 mM in H2O) and 2-[4-{(bis[(1-
tert-butyl-1H-1,2,3-triazol-4-yl)methyl]amino)methyl}-1H-1,2,3-triazol-1-yl]acetic acid 
(BTTAA) (2.5 µl, 2.5 mM in DMSO:H2O, 1:3) were premixed and then added to the reaction. 
Ascorbate (5 µl, 5 mM in H2O) was added and the reaction was shaken at 1000 rpm and 25 °C 
for 1 h. Aliquots were analyzed after heating and reduction with DTT by SDS-PAGE (8 or 
12% cross-linked gels). 
 Electrophoretic transfer onto a PVDF-membrane (Millipore Immobilon-P, 0.45 μm, 
Merck, Darmstadt) was performed using a 1:1 mixture of Tris-glycine-SDS buffer (12 mM 
Tris, 96 mM glycine, 0.1% SDS) and phosphate-SDS-urea buffer (10 mM Na2HPO4, 1% SDS, 
6 M urea) (const. I = 1.0 A, max. U = 25 V, 19 min). The membrane was rinsed with water 
and methanol after transfer and blocked at 4 °C overnight with 3% BSA (Bovine Serum 
Albumin Fraction V), 0.2% Tween 20 in PBS (140 mM NaCl, 10 mM phosphate, pH 7.4). 
For biotin detection, the blocked membrane was incubated for 1 h at room temperature with 
streptavidin-horse radish peroxidase conjugate (ThermoFisher Scientific, Rockford, Illinois), 
diluted 1:30’000 from a stock solution (1 mg/ml) with 3% BSA + 0.2% Tween 20 in PBS. 
Subsequently, the membrane was washed 4 x 5 min with PBS and incubated for 5 min with 
chemiluminescence-substrate (Pierce Super Signal West Pico, 0.07 ml/cm2 membrane). 
Chemiluminescence was detected by exposing the membrane to Kodak X-Omat LS film 
(VWR, Radnor, PA). 
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Results and Discussion 
Polymyxin B is produced naturally as a mixture containing different fatty N-acyl groups 
(Figure 1) [1]. Moreover, extensive structure-activity relationship (SAR) studies on synthetic 
polymyxin B derivatives were available to guide here the design of a photoprobe [3]. For 
example, the D-Phe6-L-Leu7 segment of the macrocycle (Figure 1) forms a hydrophobic and 
characteristic ß-turn-like structure, and conservative amino acid substitutions at these 
positions can be made without a major loss of antimicrobial activity (colistin contains D-Leu6-
L-Leu7) [20]. The L-Leu7 residue was replaced here by L-photoleucine [21] in the photoprobe 
Pal-PMB (Figure-1), so as to include a diazirine as a photo-reactive group [22]. Upon 
irradiation by UV light at ca. 350 nm, the diazirine is converted into a highly reactive carbene 
suitable for protein labeling [23]. For detection of photolabeled proteins, an alkyne was 
introduced at the N-terminus in the form of an oct-7-ynoyl group (Figure 1), since fatty acyl 
chains with 7-9 carbon atoms typically show optimal antimicrobial activity against E. coli [3]. 
After photolabeling, this allows use of "click chemistry" (alkyne + azide) to introduce a biotin 
derivative [24]. Biotinylated proteins can then be detected after gel electrophoresis by 
chemiluminescence detection with streptavidin-horse radish peroxidase conjugates. The target 
of our first synthetic efforts was, therefore, the photoprobe Pal-PMB (Figure 1). 
 The peptide backbone of Pal-PMB was assembled on 2-chlorotrityl chloride resin 
using standard Fmoc-chemistry, except that an orthogonal Alloc protecting group was used 
for the side chain of Dab4, to allow selective deprotection and subsequent macrocyclization 
(Scheme 1). However, the N-terminal octynoyl group was not added before macrocyclization, 
because the alkyne group proved to be sensitive to reduction under conditions typically used 
for Pd-catalyzed removal of the Alloc group. Instead, an Fmoc group was retained at the N-
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terminus of the linear resin-bound decapeptide. The Dab(Alloc)4 group could then be removed 
selectively on-resin, and the linear protected peptide was released from the resin with 0.8% 
TFA in DCM. Subsequently, cyclization was performed in dilute DMF/DMSO solution using 
diphenylphosphoryl azide for activation and N-methylmorpholine as a base. These conditions 
suppressed epimerization of the Thr10 Cα position, which was a problem when 
HBTU/HOBT/iPr2NEt was used for cyclization. The Fmoc group was then removed, the 
octynoyl group was coupled to the N-terminus, and the side chain protecting groups were 
finally removed using TFA, all in good yield. The photoprobe Pal-PMB was obtained in 
>98% purity and high-resolution electrospray MS confirmed the expected mass. For later 
comparisons, polymyxin B3 was also synthesized by analogous methods. The 1H NMR 
spectrum of Pal-PMB showed for all residues (except PhotoLeu7), very similar chemical shifts 
to those of polymyxin B3 in H2O/D2O (9:1), pH 3.0 (see supporting information), suggesting 
that both macrocyclic peptides have similar average backbone conformations in solution. The 
antimicrobial activity of Pal-PMB and the synthetic polymyxin B3 was measured against E. 
coli ATCC25922 and P. aeruginosa PAO1 in Mueller-Hinton II broth in the presence of 
0.02% BSA using a standard antimicrobial susceptibility assay [18]. The minimal inhibitory 
concentration (MIC) for Pal-PMB was 0.12 µg/ml against both E. coli and P. aeruginosa, 
whereas for polymyxin B3 the MICs were both 0.06 µg/ml. These results show that the 
photoprobe retains potent antimicrobial activity against both Gram-negative bacteria. 
 As an initial proof-of-principle study, a protocol was established to determine by 
photolabeling whether the probe Pal-PMB interacts with any OM proteins in the test strain E. 
coli ATCC25922. This strain is a clinical isolate that is often used in antimicrobial 
susceptibility assays, and so was used here for a photolabeling trial. The labeling protocol 
(Figure 2) included UV-irradiation (350 nm) of cells in the presence of Pal-PMB. A modified 
carbonate extraction method was then used to isolate OM proteins [25]. A click reaction was 
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performed with the OM protein fraction dissolved in phosphate buffer with SDS, using the 
Cu(I)-stabilizing ligand BTTAA [26], the biotin-PEG2-N3 derivative shown in Figure 2, 
CuSO4 and ascorbate as reducing agent. The mixture of membrane proteins was then 
separated in 8% and 12% cross-linked SDS-polyacrylamide gels, and then transferred by 
electroblotting onto a PVDF membrane using buffer conditions optimized for large bacterial 
membrane proteins [27,28]. Finally, biotin-labeled proteins could be detected on the PVDF 
membrane using a sensitive chemiluminescence assay with horse-radish-peroxidase linked to 
streptavidin. 
 The results of the photolabeling experiment, shown in Figure 3, clearly reveal 
photolabeling of several membrane proteins in the size range 15-40 kDa, ≈50 kDa and ≈100 
kDa. A negative control experiment, performed in the same way but without addition of the 
Pal-PMB photoprobe, showed as expected no chemiluminescence signals. The Coomassie 
stained gels, also shown in Figure 3, reveal bands in the 15-45 kDa size range for some of the 
most abundant OM proteins in E. coli, including OmpA/C/F. Other less abundant OM 
proteins in E. coli of ≈50 kDa include the maltose and fatty acid transporters LamB and FadL 
amongst others. OM proteins in the ≈100 kDa size range include a number of OM transporters 
and OM protein folding catalysts required for the biogenesis of the OM, which are present in 
cells only at low copy numbers. The relative intensities of the bands seen in these Western 
blots are unlikely to correspond directly to the relative amounts of individual photolabeled 
OM proteins, because the intensities can be influenced by the efficiency of transfer from the 
gel to the membrane during electroblotting, which is influenced by protein size and properties 
(hydrophobicity). However, the results shown in Figure 3 clearly reveal selective 
photolabeling of a group of membrane proteins extracted from this E. coli strain. A more 
detailed genomic (the genome sequence of the strain used has so far not been reported) and 
proteomic study now seems warranted to identify these photolabeled proteins and to 
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determine whether their interaction with polymyxin might play a role in uptake of the 
antibiotic and its permeabilizing effect on the OM. 
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Supporting Information 
Additional supporting information (NMR spectra) may be found in the online version of this 
article at the publisher’s web site. 
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Figure and Scheme legends 
Figure 1. Structures of polymyxins B1-B3 and the photoprobe Pal-PMB. In Pal-PMB the L-
Leu7 residue is replaced by L-photoleucine (PhotoLeu7), and an oct-7-ynoyl fatty acid is 
added at the N-terminus. 
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Figure 2. Outline of the photolabeling experiment (see text). 
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Figure 3. Chemiluminescence detection of biotin-labeled OM proteins after photolabeling 
(lanes marked 2) compared to a control experiment showing OM proteins isolated without 
photolabeling (lanes marked 1). A, C, show Coomassie stained SDS-PAGE gels (left 8% 
cross-linking, right 12% cross-linking); B, D, show chemiluminescence detection of 
biotinylated photolabeled OM proteins after blotting to a PVDF membrane. The 12% gel 
allows better separation of smaller (<70 kDa) proteins. 
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Scheme 1. Synthetic route to the photoprobe Pal-PMB. 
 
 
 
 
 
  
 
 
